Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, Institut IMAGINE, INSERM, Paris, France.
INM, University of Montpellier, INSERM, Montpellier, France.
Methods Mol Biol. 2022;2537:81-95. doi: 10.1007/978-1-0716-2521-7_6.
In Metazoa, the diversity of transcripts produced by the RNA Polymerase II is generated essentially through post-transcriptional processing of the nascent transcripts. The regulation of exon inclusion by alternative splicing is one of the main sources of this diversity, which leads to the expansion of the proteome. The portfolio of alternative transcripts remains largely underestimated. Improvement of the sequencing technologies has enhanced the characterization of RNA isoforms and led to the perpetual incrementation of gene expression diversity. Here, we describe a high throughput approach to assess in-depth the splicing regulation of target gene(s) using the third-generation sequencing (TGS) technologies.
在后生动物中,RNA 聚合酶 II 产生的转录本的多样性主要是通过新生转录本的转录后加工产生的。通过选择性剪接调节外显子的包含是这种多样性的主要来源之一,它导致了蛋白质组的扩展。选择性转录本的组合在很大程度上仍然被低估。测序技术的改进增强了对 RNA 异构体的特征描述,并导致基因表达多样性的不断增加。在这里,我们描述了一种高通量的方法,使用第三代测序 (TGS) 技术深入评估靶基因 (s) 的剪接调控。